Antiparasitics acting on endo-or ectoparasites represent the second largest segment of the
global animal health market, accounting for 23% of market share. However, relatively few …

Canine leishmaniosis is an important vector‐borne zoonosis caused mainly by Leishmania
infantum. Diagnosis and treatment of affected individuals can be particularly complex …

Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a
broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous …

Leishmaniasis includes a spectrum of diseases ranging from debilitating cutaneous to fatal
visceral infections. This disease is caused by the parasitic protozoa of the genus Leishmania …

Leishmaniasis is a vector-borne disease caused by an intracellular parasite of the genus
Leishmania with different clinical manifestations that affect millions of people worldwide …

Post-kala-azar dermal leishmaniasis (PKDL) is a chronic, stigmatizing skin condition
occurring frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent …

The aim of the present study was to encapsulate lipophosphoglycan molecule (LPG) which
is one of the most immunogenic antigens of Leishmania parasites into PLGA nanoparticles …

Background Visceral leishmaniasis (VL) caused by dimorphic Leishmania species is a
parasitic disease with high socioeconomic burden in endemic areas worldwide. Sustaining …

Experimental and epidemiological evidence shows that parasites, particularly helminths,
play a central role in balancing the host immunity. It was demonstrated that parasites can …

Leishmaniasis is a vector-borne neglected tropical disease endemic in over 100 countries
around the world. Available control measures are not always successful, therapeutic options …